FDA Investigator Dr. Dominick Roselle
Dr. Dominick Roselle has inspections in 1 countries as of 21 Jul 2023. Dr. Dominick Roselle has collaborated with a combined 1410 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
21 Jul 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alice S Tsao,
Alison N Stieg,
Barbara A Gullick,
Bijoy Panicher,
Bijoy Panicker,
Brooke K Higgins,
CDR Ileana Barreto Pettit,
Chaltu N Wakijra,
Chiang Syin, PhD,
Christina K Theodorou,
Christos G Tsingelis,
Daryl A Dewoskin,
David A Oluwo,
Douglas A Campbell,
Dr. Roslyn F Powers,
Dr. Yubing Tang,
Edmund F Mrak, Jr,
Edward H Maticka,
Emest F Bizjak,
Erik W Koester,
Erk W Koester,
George Pyramides,
Hector J Colon Torres,
James M Mason,
James M Simpson,
Jennifer A Robinson,
Jennifer Lalama,
Jessica L Pressley,
Jogy George,
Jonah S Ufferfilge,
Jonah Ufferfilge,
Jonathan W Chapman,
Jose Perez Soto,
Joseph W Matthews,
Joshua J Silvestri,
Junho Pak,
Kathleen M Jordan,
Kenneth Gordon,
Kenneth M Gordon,
Kenneth Nieves,
Ko U Min,
Kristina L Conroy,
Lawrence Harmon, Jr,
LCDR Michael H Tollon,
Lori S Lawless,
Lourdes Andujar,
LT Kimberly M Hull,
Luis M Burgos Medero,
Lynne Ensor,
Marcellinus D Dordunoo,
Marcus A Ray,
Margaret M Doherty,
Matthew M Henciak,
Melissa J Garcia,
Michael Shanks, MS,
Moraima J Ramos Valle,
Nebil A Oumer,
Nicholas A Violand,
Nicole E Knowlton,
Paul L Figarole, Jr,
Rachael O Oyewole,
Rachael Oyewole,
Rachel C Harrington,
Robert J Martin,
Rosario D'costa,
Saleem A Akhtar,
Salvatore N Randazzo,
Sharon K Thoma, PharmD,
Shirshendu K Deb, PhD,
Simone E Pitts,
Tonia F Bernard,
Toyin B Oladimeji,
Viviana Matta,
Vivin George,
Walter L Fava,
Wanda Y Honeyblue,
Yvins Dezan,
Zhongren Wu
Dr. Dominick Roselle's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2000 | FDA 483 Response | Catalent Pharma Solutions, LLC - Form 483R, 2000-08-01 |
July, 2000 | EIR | Catalent Pharma Solutions, LLC - EIR, 2000-07-21 |
July, 2000 | FDA 483 | Catalent Pharma Solutions, LLC - Form 483, 2000-07-21 |
May, 2004 | FDA 483 Response | Pharmaceutics International, Inc. - Form 483R, 2004-05-20 |
May, 2004 | FDA 483 | Pharmaceutics International, Inc. - Form 483, 2004-05-24 |
May, 2004 | EIR | Pharmaceutics International, Inc. - EIR, 2004-06-29 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more